Journal article

Ocular Tissue for Research in Australia: Strategies for Potential Research Utility of Surplus and Transplant-Ineligible Deceased Donations

Heather Machin, Karl Brown, Gerard Sutton, Paul Baird



A 2016 Price Waterhouse Cooper Report, commissioned by the Australian Commonwealth Government's Organ and Tissue Authority, indicated that Australia had been meeting its human ocular tissue for transplant needs. It further suggested that Australia should consider exportation as a management strategy for excess tissue. Although we do not seek to discuss how the Price Waterhouse Cooper Report determined that need was being met, nor the potential value of exportation in this article, we propose that Ocular Tissue for Research (OTR), and particularly identification of donors for research, and timely access to fresh domestic tissue, be considered as an alternate or simultaneous surplus management..

View full abstract


Awarded by Australian National Health and Medical Research Council (NHMRC)

Funding Acknowledgements

The authors thank Lisa Buckland, Anne-Maree Farrell, Marisa Herson, and Graeme Pollock for technical advice.Compliance with Ethical Standards: This article does not contain any studies with human or animal participants performed by any of the authors.H. Machin: Postgraduate Scholarship supported by the Australian National Health and Medical Research Council (NHMRC) ID:APP1150637; G. Sutton: For reference, G. Sutton is the Medical Director with responsibilities to the Australian Ocular Biobank, which is part of the Organ and Tissue Donation Service (OTDS) Public Health; P. Baird: Senior Research Fellowship Supported by the Australian National Health and Medical Research Council (NHMRC) ID:1138585. Note: The Centre for Eye Research Australia (H. Machin and K. Brown employer) receives Operational Infrastructure Support from the Victorian Government.